Moreover, GLP-1 RAs combined with SGLT2 inhibitors positively impact systolic blood pressure (SBP), A1C level, and body weight in elderly T2DM patients [56]. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.